Literature DB >> 20143334

Profilin-1 overexpression inhibits proliferation of MDA-MB-231 breast cancer cells partly through p27kip1 upregulation.

Li Zou1, Zhijie Ding, Partha Roy.   

Abstract

Profilin-1 (Pfn1), a ubiquitously expressed actin-binding protein, has gained interest in epithelial-derived cancer because of its downregulation in expression in various adenocarcinoma. Pfn1 overexpression impairs tumorigenic ability of human breast cancer xenografts thus suggesting that Pfn1 could be a tumor-suppressor protein. The objective of the present study was to determine how Pfn1 overexpression affects cell-cycle progression of breast cancer cells. We show that Pfn1 overexpression in MDA-MB-231 breast cancer cells causes cell-cycle arrest in G1 phase and dramatically reduced proliferation in culture. Pfn1 overexpression results in increased protein stability of p27(kip1) (p27-a major cyclin-dependent kinase inhibitor) and marked elevation in the overall cellular level of p27. Proliferation defect of Pfn1 overexpressers can be partly rescued by silencing p27 expression thus suggesting a critical role of p27 in Pfn1-induced growth inhibition of MDA-MB-231 cells. Finally, Pfn1 overexpression was found to sensitize MDA-MB-231 cells to apoptosis in response to cytotoxic stimulus thus suggesting for the first time that survival of breast cancer cells can also be negatively influenced by Pfn1 upregulation. These findings may provide novel insights underlying Pfn1's tumor-suppressive action. (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20143334      PMCID: PMC2872929          DOI: 10.1002/jcp.22058

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  36 in total

1.  Breast cancer banishes p27 from nucleus.

Authors:  Stacy W Blain; Joan Massagué
Journal:  Nat Med       Date:  2002-10       Impact factor: 53.440

Review 2.  The role of profilin complexes in cell motility and other cellular processes.

Authors:  Walter Witke
Journal:  Trends Cell Biol       Date:  2004-08       Impact factor: 20.808

3.  Phosphorylation of p27Kip1 on serine 10 is required for its binding to CRM1 and nuclear export.

Authors:  Noriko Ishida; Taichi Hara; Takumi Kamura; Minoru Yoshida; Keiko Nakayama; Keiichi I Nakayama
Journal:  J Biol Chem       Date:  2002-03-11       Impact factor: 5.157

4.  p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest.

Authors:  K Polyak; J Y Kato; M J Solomon; C J Sherr; J Massague; J M Roberts; A Koff
Journal:  Genes Dev       Date:  1994-01       Impact factor: 11.361

5.  PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest.

Authors:  Jiyong Liang; Judit Zubovitz; Teresa Petrocelli; Rouslan Kotchetkov; Michael K Connor; Kathy Han; Jin-Hwa Lee; Sandra Ciarallo; Charles Catzavelos; Richard Beniston; Edmee Franssen; Joyce M Slingerland
Journal:  Nat Med       Date:  2002-09-16       Impact factor: 53.440

Review 6.  Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression.

Authors:  Jiyong Liang; Joyce M Slingerland
Journal:  Cell Cycle       Date:  2003 Jul-Aug       Impact factor: 4.534

7.  Tumor suppressor activity of profilin requires a functional actin binding site.

Authors:  Nina Wittenmayer; Burkhard Jandrig; Martin Rothkegel; Kathrin Schlüter; Wolfgang Arnold; Wolfgang Haensch; Siegfried Scherneck; Brigitte M Jockusch
Journal:  Mol Biol Cell       Date:  2004-02-06       Impact factor: 4.138

8.  A Formin Homology protein and a profilin are required for cytokinesis and Arp2/3-independent assembly of cortical microfilaments in C. elegans.

Authors:  Aaron F Severson; David L Baillie; Bruce Bowerman
Journal:  Curr Biol       Date:  2002-12-23       Impact factor: 10.834

9.  Suppression of tumorigenicity in breast cancer cells by the microfilament protein profilin 1.

Authors:  J Janke; K Schlüter; B Jandrig; M Theile; K Kölble; W Arnold; E Grinstein; A Schwartz; L Estevéz-Schwarz; P M Schlag; B M Jockusch; S Scherneck
Journal:  J Exp Med       Date:  2000-05-15       Impact factor: 14.307

10.  PTEN loss of expression predicts cetuximab efficacy in metastatic colorectal cancer patients.

Authors:  M Frattini; P Saletti; E Romagnani; V Martin; F Molinari; M Ghisletta; A Camponovo; L L Etienne; F Cavalli; L Mazzucchelli
Journal:  Br J Cancer       Date:  2007-10-16       Impact factor: 7.640

View more
  24 in total

1.  Using proteomic approach to identify tumor-associated proteins as biomarkers in human esophageal squamous cell carcinoma.

Authors:  Jintao Zhang; Kaijuan Wang; Jianzhong Zhang; Samuel S Liu; Liping Dai; Jian-Ying Zhang
Journal:  J Proteome Res       Date:  2011-05-03       Impact factor: 4.466

2.  Epithelial morphological reversion drives Profilin-1-induced elevation of p27(kip1) in mesenchymal triple-negative human breast cancer cells through AMP-activated protein kinase activation.

Authors:  Chang Jiang; William Veon; Hui Li; Kenneth R Hallows; Partha Roy
Journal:  Cell Cycle       Date:  2015-07-15       Impact factor: 4.534

3.  Expression and regulatory function of miRNA-182 in triple-negative breast cancer cells through its targeting of profilin 1.

Authors:  Hailing Liu; Yan Wang; Xin Li; Yan-jun Zhang; Jie Li; Yi-qiong Zheng; Mei Liu; Xin Song; Xi-ru Li
Journal:  Tumour Biol       Date:  2013-02-22

Review 4.  Profilin: many facets of a small protein.

Authors:  Rhonda J Davey; Pierre Dj Moens
Journal:  Biophys Rev       Date:  2020-07-13

5.  Subcellular localization and Ser-137 phosphorylation regulate tumor-suppressive activity of profilin-1.

Authors:  Marc I Diamond; Shirong Cai; Aaron Boudreau; Clifton J Carey; Nicholas Lyle; Rohit V Pappu; S Joshua Swamidass; Mina Bissell; Helen Piwnica-Worms; Jieya Shao
Journal:  J Biol Chem       Date:  2015-02-13       Impact factor: 5.157

6.  Silencing profilin-1 inhibits gastric cancer progression via integrin β1/focal adhesion kinase pathway modulation.

Authors:  Ya-Jun Cheng; Zhen-Xin Zhu; Jian-Sheng Zhou; Zun-Qi Hu; Jian-Peng Zhang; Qing-Ping Cai; Liang-Hua Wang
Journal:  World J Gastroenterol       Date:  2015-02-28       Impact factor: 5.742

7.  A balanced level of profilin-1 promotes stemness and tumor-initiating potential of breast cancer cells.

Authors:  Chang Jiang; Zhijie Ding; Marion Joy; Souvik Chakraborty; Su Hyeong Kim; Ralph Bottcher; John Condeelis; Shivendra Singh; Partha Roy
Journal:  Cell Cycle       Date:  2017       Impact factor: 4.534

8.  Profilin-1 overexpression in MDA-MB-231 breast cancer cells is associated with alterations in proteomics biomarkers of cell proliferation, survival, and motility as revealed by global proteomics analyses.

Authors:  Joëlle V F Coumans; David Gau; Anne Poljak; Valerie Wasinger; Partha Roy; Pierre D J Moens
Journal:  OMICS       Date:  2014-12

9.  Profilin 1 is a potential biomarker for bladder cancer aggressiveness.

Authors:  Jerome Zoidakis; Manousos Makridakis; Panagiotis G Zerefos; Vasiliki Bitsika; Sergio Esteban; Maria Frantzi; Konstantinos Stravodimos; Nikolaos P Anagnou; Maria G Roubelakis; Marta Sanchez-Carbayo; Antonia Vlahou
Journal:  Mol Cell Proteomics       Date:  2011-12-08       Impact factor: 5.911

10.  Profilin choreographs actin and microtubules in cells and cancer.

Authors:  Morgan L Pimm; Jessica Hotaling; Jessica L Henty-Ridilla
Journal:  Int Rev Cell Mol Biol       Date:  2020-07-16       Impact factor: 6.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.